DIHYDROPYRIMIDINE DERIVATIVES AND USES THEREOF IN THE TREATMENT OF HBV INFECTION OR OF HBV-INDUCED DISEASES

METHODS OF KILLING OR INHIBITING THE GROWTH OF CANCER CELLS

Cereblon ligands and bifunctional compounds comprising the same

METHODS OF GENERATING AND USING SENESCENT-INDUCED CELLS FOR TREATMENT OF CANCER AND COMPOSITIONS RELATING THERETO

COMPOSITIONS AND METHODS FOR THE TREATMENT OF RESPIRATORY SYNCYTIAL VIRUS

METHODS OF TREATING AN INFLAMMATORY OR OBSTRUCTIVE AIRWAY DISEASE USING ANTI-TSLP ANTIBODY

Topical therapeutic formulations

Diagnostic and therapeutic methods for cancer

PATCH PRODUCT BASED ON NATURAL POLYMERS

METHOD OF ELECTROSPINNING NATURAL POLYMERS

Use of sublingual dexmedetomidine for the treatment of agitation

CARBONIC ANHYDRASE II COMPOSITIONS AND METHODS OF USE THEREOF

COMPOSITIONS AND METHODS FOR MICROGLIA REPLACEMENT THERAPY

Conjoint therapies for immunomodulation

COMPOSITIONS AND METHODS FOR USE IN IMMUNOTHERAPY

FORMULATIONS FOR DELIVERY TO THE EAR

SEMG2 ANTIBODY AND USE THEREOF

METHODS AND COMPOSITIONS FOR ANTIMICROBIAL USE OF SYNTHETIC LYSINE ANALOGS, DERIVATIVES, AND MIMETICS, AND PRODRUGS

Compounds for treating TNBC

DAMAGE-TARGETED TREATMENTS OF DISEASE

KHK INHIBITORS

GALACTOSE-LINKED MULTIMERIC GLYCOMIMETIC INHIBITORS OF E-SELECTINS, GALECTIN-3, AND/OR CXCR4 CHEMOKINE RECEPTORS

Sensitizing composition using electromagnetic waves for thermal therapy of cancers, and cancer therapy using same

Immunogenic compositions for treatment of Hepatitis B

COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH NLRP ACTIVITY

PULSATILE DRUG DELIVERY SYSTEM FOR TREATING MORNING AKINESIA

Replication stress pathway agent compositions and methods for treating cancer

Fasting-mimicking diet (FMD) but not water-only fasting promotes reversal of inflammation and IBD pathology

INHIBITORS OF FIBROBLAST GROWTH FACTOR RECEPTOR KINASES

Apoaequorin and Curcumin Containing Compositions and Methods

CELL COMPOSITIONS AND METHODS FOR CANCER THERAPY

ANTI-MULLERIAN HORMONE RECEPTOR 2 ANTIBODIES AND METHODS OF USE

METHODS OF USING MOMELOTINIB TO TREAT JOINT INFLAMMATION

Pharmaceutical compositions containing mixed polymeric micelles

Method for producing a drug delivery system

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS

BCL-W Polypeptides and Mimetics for Treating or Preventing Chemotherapy-Induced Peripheral Neuropathy and Hearing Loss

ANTI-EGFR ANTIBODY DRUG CONJUGATES

INTRAVENOUS FORMULATIONS OF RK-33

METHODS FOR MODULATING CALORIE CONSUMPTION

AMIDO-SUBSTITUTED HETEROCYCLIC COMPOUNDS AND METHODS OF USE THEREOF FOR THE TREATMENT OF HERPES VIRUSES

Optimization of Antibodies that Bind Lymphocyte Activation Gene-3 (LAG-3), and Uses Thereof

THERAPEUTIC COMPOUNDS FOR METHODS OF USE IN INSULIN RESISTANCE

Combination Therapy

SHORT HAIRPIN RNA (SHRNA734) AND USE OF SAME TO POSITIVELY SELECT AND ELIMINATE GENETICALLY MODIFIED CELLS

MESENCHYMAL STEM CELLS AND USES THEREFOR

Polymorphisms of HM30181 mesylate

USES OF BIOMARKERS FOR IMPROVING IMMUNOTHERAPY

METHODS AND COMPOSITIONS FOR TREATING CANCER OR VIRAL INFECTION WITH A PLA2G2D ANTAGONIST

FAST-ACTING PLANT-BASED MEDICINAL COMPOUNDS AND NUTRITIONAL SUPPLEMENTS

KETONE BODIES AND KETONE BODY ESTERS AS BLOOD LIPID LOWERING AGENTS

IDENTIFICATION OF AN EGFR-BIN3 PATHWAY THAT ACTIVELY SUPPRESSES INVASION AND REDUCES TUMOR SIZE IN GLIOBLASTOMA

Functionalized heterocycles as antiviral agents

METHOD FOR ISOLATING AND PURIFYING MESENCHYMAL STEM CELLS FROM HERNIA SAC AND METHOD FOR TISSUE REPAIR BY USING MESENCHYMAL STEM CELLS FROM HERNIA SAC

COMBINATION OF DILTIAZEM AND VIRAL POLYMERASE INHIBITORS

BORTEZOMIB-LOADED NANOPARTICLES

Combination therapy for cancer treatment

PHYSICS-DRIVEN DISCOVERY OF NOVEL SMALL THERAPEUTIC COMPOUNDS FOR USE AS A BCL-2 INHIBITOR

Cycloalkane-1,3-diamine derivative

ADIPONECTIN PEPTIDOMIMETICS FOR TREATING OCULAR DISORDERS

CELL IMMUNOTHERAPY FOR THE TREATMENT OF CANCER

COMPOSITIONS COMPRISING PIG STOMACH MUCINS AND USES THEREOF

Multi chamber flexible bag and methods of using same

COMPOUNDS FOR USE IN THE TREATMENT OF LEUKEMIA

Sulfonyl piperidine derivatives and their use for treating prokineticin mediated diseases

DRG-MDM2-1 FOR USE AS A NOVEL MOUSE DOUBLE MINUTE 2 (MDM2) INHIBITOR

PARAXANTHINE-BASED BIOACTIVE COMPOSITION AND METHOD OF USE THEREOF

Engineered immunostimulatory bacterial strains and uses thereof

POLYPEPTIDE COMPOSITIONS AND USES THEREOF

TARGETED RADIOPHARMACEUTICALS FOR THE DIAGNOSIS AND TREATMENT OF PROSTATE CANCER

Pan-Genotypic Agents Against Influenza Virus and Methods of Using the Same

Stimulation of Human Meibomian Gland Function

METHOD OF PROVIDING ARIPIPRAZOLE TO PATIENTS HAVING IMPAIRED CYP2D6 OR CYP3A4 ENZYME FUNCTION

NOVEL USES

BIFUNCTIONAL ANTI-PD-1/IL-7 MOLECULE

HETEROCYCLIC GLP-1 AGONISTS

Sigma-1 receptor agonist systolic blood pressure therapy

DRG-MDM2-4 FOR USE AS A NOVEL MOUSE DOUBLE MINUTE 2 (MDM2) INHIBITOR

PROTEIN TYROSINE KINASE 6 (PTK6) DEGRADATION / DISRUPTION COMPOUNDS AND METHODS OF USE

Combination therapy for treating or preventing depression or other mood diseases

SHP2 Inhibitor Dosing and Methods of Treating Cancer

TREATMENT OF CARDIAC ARRHYTHMIA USING BOTULINUM TOXIN

Multiple Unit Dosage Form Having A Therapeutic Agent In Combination With A Nutritional Supplement

Anti-VTCN1 antibodies and antibody drug conjugates

Enhancement of tumor response to chemotherapy by activation of the asmase/ceramide pathway through timed administration of a short-acting anti-angiogenic agent

METHODS OF USING ANDROGRAPHOLIDE, ORIDONIN AND ISOLIQUIRITIGENIN AND DERIVATIVES THEREOF

N-(3-AMINO-3-OXOPROPYL)-2-[(1-METHYL-4-NITRO-1H-IMIDAZOL-5-YL)THIO]BENZAMIDE AND ITS USE FOR TREATING HIV INFECTION

Combination therapy with apilimod and glutamatergic agents

Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitors

STABILIZATION OF AQUEOUS COMPOSITIONS OF PROTEINS WITH DISPLACEMENT BUFFERS

NOVEL LILRB2 ANTIBODIES AND USES THEREOF

REAL-TIME MONITORING OF IN VIVO FREE RADICAL SCAVENGERS THROUGH HYPERPOLARIZED N-ACETYL CYSTEINE ISOTOPES

DRG-MDM2-3 FOR USE AS A NOVEL MOUSE DOUBLE MINUTE 2 (MDM2) INHIBITOR

TREATMENT OF OTIC DISEASES AND CONDITIONS

Anti-aging drug combination and use thereof

METHODS FOR TREATING INFLAMMATORY CONDITIONS OF THE LUNGS

Caffeine inhibitors of MTHFD2 and uses thereof

Compositions comprising phosphoinositide 3-kinase inhibitors and a second antiproliferative agent

MEDICAL SHEET

Methods of administration for highly water-soluble salts of a short acting phenylalkylamine calcium channel blocker

ELOVL2 constructs for human gene therapy

CD123-binding polypeptides and uses thereof

3-(ANILINO)-2-[3-(3-ALKOXY-PYRIDIN-4-YL]-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE DERIVATIVES AS EGFR INHIBITORS FOR THE TREATMENT OF CANCER

HETEROCYCLIC DERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND THEIR USE IN THE TREATMENT OR AMELIORATION OF CANCER

SUBSTITUTED AMINOQUINOLONES AS DGKALPHA INHIBITORS FOR IMMUNE ACTIVATION

COMPOSITIONS, KITS AND METHODS FOR ENHANCING THERAPEUTIC COMPLIANCE

METHODS AND COMPOSITIONS TO INHIBIT SYMPTOMS ASSOCIATED WITH VEISALGIA

Substituted pyrido[2,3-d]pyrimidines as inhibitors of Ras pathway signaling

REDUCING SIDE EFFECTS OF NMDA ANTAGONISTS

METHODS FOR TREATING CANCER AND THE USE OF BIOMARKERS AS A PREDICTOR OF CLINICAL SENSITIVITY TO THERAPIES

4′-phosphate analogs and oligonucleotides comprising the same

Dosage regime with esketamine for treating major depressive disorder

DNA-PK INHIBITING COMPOUNDS

DRG-MDM2-5 FOR USE AS A NOVEL MOUSE DOUBLE MINUTE 2 (MDM2) INHIBITOR

ANTI-ASGR1 ANTIBODY CONJUGATES AND USES THEREOF

Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitors

DUAL INHIBITORS OF TIM-3 AND PD-1 PATHWAYS

DAP12 constructs and their use to enhance DC vaccines and immunotherapies

Methods for Determining the Likelihood of Survival and for Predicting Likelihood of Metastasis in Cancer Patients

ALKYNE CONTAINING NUCLEOTIDE AND NUCLEOSIDE THERAPEUTIC COMPOSITIONS AND USES RELATED THERETO

SUBSTITUTED AMINOQUINOLONES AS DGKALPHA INHIBITORS FOR IMMUNE ACTIVATION

TETRAHYDROQUINOLINE COMPOSITIONS AS BET BROMODOMAIN INHIBITORS

HUMAN MONOCLONAL ANTIBODIES TO PROGRAMMED DEATH LIGAND 1 (PD-L1)

Pharmaceutical composition for improving health, cure abnormalities and degenerative disease, achieve anti-aging effect of therapy and therapeutic effect on mammals and method thereof

METHODS OF MINIMIZING NEUROTOXICITY ASSOCIATED WITH CHIMERIC ANTIGEN RECEPTOR (CAR) T CELL THERAPY

METHODS AND COMPOSITIONS FOR STIMULATION AND ENHANCEMENT OF REGENERATION OF TISSUES

SELECTION OF PATIENTS FOR COMBINATION THERAPY

Targeting Mcl-1 to Enhance DNA Replication Stress Sensitivity for Cancer Therapy

Drug device configured for wireless communication

CRENOLANIB FOR TREATING TRK KINASE ASSOCIATED PROLIFERATIVE DISORDERS

Treatment of mitochondrial diseases

Use of NMN for the prevention and/or treatment of joint pain induced by physical activity, and corresponding compositions

COMBINATION TREATMENT OF LIVER DISEASES USING INTEGRIN INHIBITORS

Methods and compositions for increasing the potency of antifungal agents

METHOD FOR TREATING ATHLETES SUBJECT TO PATHOLOGICAL CARDIAC HYPERTROPHY BY ADMINISTERING NIGELLA SATIVA

Inhibitors of bacterial pasta kinases

DRUG DELIVERY SYSTEMS AND TARGETED RELEASE OF PHARMACEUTICAL AGENTS WITH FOCUSED ULTRASOUND

Methods for ameliorating infusion reactions

Modulation Of Endoplasmic Reticulum Aminopeptidase 2 (ERAP2)-Mediated Immune Response

LIPOSOMAL FORMULATIONS OF BCL INHIBITORS

Novel TAS2R38 Bitter Taste Receptor Agonist

METHODS FOR TREATING ATOPIC DERMATITIS BY ADMINISTERING AN IL-4R ANTAGONIST

METABOLITE-BASED POLYMERS, MICROPARTICLES, AND NANOPARTICLES FOR IMMUNOTHERAPY AND METHODS OF TREATING A DISEASE OR DISORDER

METHOD OF DIAGNOSIS, PROGNOSIS, AND TREATMENT OF VITAMIN D DEFICIENCY AND VITAMIN D IMBALANCE AND DISEASES AND DISORDERS ASSOCIATED THEREOF

MEDICINAL COMPOSITIONS FOR CARBON DIOXIDE BASED METERED DOSE INHALERS

CO-CRYSTALS OF TRAMADOL AND COXIBS

COMPOSITIONS AND METHODS OF USE THEREOF FOR TREATMENT OF MASTITIS

ANTITUMOR VIRUS

USE OF H3K9me3 MODULATION FOR ENHANCING COGNITIVE FUNCTION

RAB13 AND NET1 ANTISENSE OLIGONUCLEOTIDES TO TREAT METASTATIC CANCER

GENE NETWORKS THAT MEDIATE REMYELINATION OF THE HUMAN BRAIN

A CONJUGATE OF AN AMANITA TOXIN WITH BRANCHED LINKERS

Phenoxy-pyridyl-pyrimidine compounds and methods of use

DRY LIPOSOME FORMULATIONS AND RELATED METHODS THEREOF

USES OF ANTI-TGF-BETA ANTIBODIES AND CHECKPOINT INHIBITORS FOR THE TREATMENT OF PROLIFERATIVE DISEASES

Therapy for the Treatment of Cancer

MONOMER AND MULTIMERIC ANTI-HBV AGENTS

Method for enhancing expression of insulin like growth factor 1 receptor in umbilical cord mesenchymal stem cell expressing IGF1R and method for obtaining multipotent umbilical cord mesenchymal stem cell

Toll-like receptor ligands

PYRIMIDOPYRROLE SPIRO COMPOUNDS AND DERIVATIVES THEREOF AS DNA-PK INHIBITORS

COMPOUNDS AND METHODS FOR THE TREATMENT OF CYSTIC FIBROSIS

METHODS AND COMPOSITIONS FOR IMPROVING KIDNEY FUNCTION IN PATIENTS WITH HEPATORENAL SYNDROME

COMPOSITIONS AND METHODS FOR TREATMENT OF CANCERS HARBORING AN H3K27M MUTATION

Compositions and methods for reducing muscle contraction

Psychoactive medicines and their use for treating psychiatric and neurological conditions and disorders

METHOD OF TREATING HER2-POSITIVE BREAST CANCER

Modulators of mas-related G-protein receptor X4 and related products and methods

PYRROLOBENZODIAZEPINE-ANTIBODY CONJUGATES

TREATMENT OF LIVER INJURY

ENHANCING EXPRESSION OF LINE-1 ENCODED ORF2P FOR CANCER THERAPEUTICS

COMBINATION THERAPIES USING CDK INHIBITORS

COMPOSITIONS AND METHODS RELATING TO MYOMAKER-INDUCED MUSCLE CELL FUSION

TOPICAL COMPOSITION FOR USE IN THE TREATMENT OF INFLAMMATORY BOWEL DISEASE

METHODS TO ALTER THE TUMOR MICROENVIRONMENT FOR EFFECTIVE CANCER IMMUNOTHERAPY

COMPOSITIONS COMPRISING KAKADU PLUM EXTRACT OR ACAI BERRY EXTRACT

Composition comprising PIC for treatment of cancer

ANTIBODIES AGAINST CD73 AND USES THEREOF

COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH NLRP ACTIVITY

SSTR5 ANTAGONISTS

PHOTOSENSITIZING ANTIBODY-FLUOROPHORE CONJUGATES

LYSIN POLYPEPTIDES ACTIVE AGAINST GRAM-NEGATIVE BACTERIA

DOSAGE REGIME WITH ESKETAMINE FOR TREATING NEUROPSYCHIATRIC OR NEUROLOGICAL CONDITIONS

PHARMACEUTICAL COMPOSITION COMPRISING TRANS - CINNAMALDEHYDE AND ITS USE IN THE TREATMENT OF INFECTIONS

PYRAZOLO[3,4-B]PYRAZINE SHP2 PHOSPHATASE INHIBITORS

TUMOR SPECIFIC ANTIBODY CONJUGATES AND USES THEREFOR

STABILIZED PHARMACEUTICAL FORMULATIONS OF INSULIN ANALOGUES AND/OR INSULIN DERIVATIVES

COMPOUNDS FOR TREATING BRAIN CANCER

COMBINED MULTISTAGE MICROBIAL PREPARATIONS AND METHOD OF THEIR APPLICATION

Anti-C-C motif chemokine receptor 8 (CCR8) antibodies and methods of use

ANTI-IL-36R ANTIBODIES FOR THE TREATMENT OF A FIBROTIC CONDITION

COMPOSITION

COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF LYMPHATIC SYSTEM DISORDERS

HETEROARYLAMINOPYRIMIDINE AMIDE AUTOPHAGY INHIBITORS AND METHODS OF USE THEREOF

COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITY

Compositions and methods for targeting nuclear import shuttles and treating inflammatory disorders

Indazole-3-carboxamides and their use as Wnt/β-catenin signaling pathway inhibitors

ALLOSTERIC MODULATORS OF CANNABINOID RECEPTORS AND METHODS OF TREATING NEUROPATHIC PAIN

TOPICAL PHARMACEUTICAL FORMULATIONS CONTAINING A LOW CONCENTRATION OF BENZOYL PEROXIDE IN SUSPENSION IN WATER AND A WATER-MISCIBLE ORGANIC SOLVENT

COMBINATION OF SMALL MOLECULE INHIBITOR OF THE PD-1/PD-L1 INTERACTION AND ANTI-PD-1 ANTIBODY FOR TREATING CANCER

Synthetic progestogens and pharmaceutical compositions comprising the same

BISPECIFIC ANTIBODIES AGAINST CHI3L1 AND CTLA4 WITH ENHANCED CYTOTOXIC EFFECTS ON TUMOR CELLS

Peptides and other agents for treating pain and increasing pain sensitivity

Tetrahydro-pyrido[3,4-b]indole estrogen receptor modulators and uses thereof

CANCER TREATMENT METHOD AND MEDICINE

SUBSTITUTED ARYLMETHYLUREAS AND HETEROARYLMETHYLUREAS, ANALOGUES THEREOF, AND METHODS USING SAME

Treatment method for colon cancer

Pharmaceutical Combinations

ANTI IL-36R ANTIBODIES COMBINATION THERAPY

METHODS TO ENHANCE BIOAVAVAILABILITY OF ORGANIC SMALL MOLECULES AND DEPOSITED FILMS MADE THEREFROM

COMPOSITIONS AND METHODS FOR POTENTIATING IMMUNE ACTIVITY

Hepatitis b core protein modulators

Phosphodiesterase-4 inhibitor combinations, methods of making, and methods of use thereof

Certain chemical entities, compositions, and methods

METHODS AND COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF DISEASE

Morphic forms of G1T38 and methods of manufacture thereof

ANTI-TAU ANTIBODIES AND METHODS OF USE

Quinazoline Compounds

Substituted pyridines, pyridazines, pyrimidines, and 1,2,3-triazines as bruton's tyrosine kinase inhibitors

Combination therapy

COMPOSITIONS AND METHODS FOR TREATMENT OF HOMOCYSTINURIA

Cardioprotective Lipid and Method of Use

Transdermal patch with separated regions for delivery of immunomodulators

NEW CRYSTALLINE FORMS OF A SUCCINATE SALT OF 7-CYCLOPENTYL-2-(5-PIPERAZIN-1-YL-PYRIDIN-2-YLAMINO)-7H-PYRROLO[2,3-D]PYRIMIDINE -6-CARBOXYLIC ACID DIMETHYLAMIDE

COMPOSITION FOR WEIGHT MANAGEMENT OF A SUBJECT

ADOPTIVE CELL THERAPY WITH ZBTB20 SUPPRESSION

ANTI-GITR ANTIBODIES AND USES THEREOF

ANTI-IL-27 ANTIBODIES AND USES THEREOF

HUMAN MONOCLONAL ANTIBODIES AGAINST INTERLEUKIN 8 (IL-8)

COMBINATIONS OF MRNAS ENCODING IMMUNE MODULATING POLYPEPTIDES AND USES THEREOF

Quinoline derivatives

ENERGETIC CANCER STEM CELLS (E-CSCS): A NEW HYPER-METABOLIC AND PROLIFERATIVE TUMOR CELL PHENOTYPE, DRIVEN BY MITOCHONDRIAL ENERGY

Pharmaceutical Formulation with Improved Solubility and Bioavailability

Compositions and methods for treating anxiety-related disorders

1′-cyano nucleoside analogs and uses thereof

KIR3DL3 IS AN INHIBITORY RECEPTOR OF THE IMMUNE SYSTEM AND USES THEREOF

T-CELL DEATH ASSOCIATED GENE 8 (TDAG8) MODULATION TO ENHANCE CELLULAR CANCER THERAPIES

ANTITUMOR DRUG FOR USE IN COMBINATION WITH IMMUNE CHECKPOINT INHIBITOR

THERAPEUTIC AMOEBA AND USES THEREOF

ANTISENSE OLIGONUCLEOTIDES FOR TREATMENT OF CANCER STEM CELLS

Benzimidazole derivative having fluorine-containing substituent, preparation and application thereof

COMPOUNDS FOR TREATING NEURODEGENERATIVE DISEASES

DOSAGE REGIMES

LYMPHOCYTE AND MONOCYTE POPULATIONS IN CANCER PATIENTS AND AUTOLOGOUS STEM CELL PREPARATIONS, AND USES THEREOF

Phenylaminopyrimidine amide autophagy inhibitors and methods of use thereof

COMPOSITIONS AND METHODS OF MODULATING SHORT-CHAIN DEHYDROGENASE ACTIVITY

CD73 compounds

COMPOSITIONS AND METHODS FOR TREATING NRP2-ASSOCIATED DISEASES

Substituted indole Mcl-1 inhibitors

2-BETA-NAPHTHYL-ACETIC ACID ANALOGS AS AKR1C3 INHIBITORS AND METHODS OF USING SAME

KIT FOR PREPARING NANOPARTICLE COMPOSITION FOR DRUG DELIVERY, COMPRISING POLYLACTIC ACID SALT

ANTIBODY MOLECULES TO CD73 AND USES THEREOF

Capsid inhibitors for the treatment of HIV

Method and compositions for the treatment of anemia through the inhibition of furin

Methods and compositions for targeting Tregs using CCR8 inhibitors

INHIBITORS OF KDM5A FOR USE IN TREATMENT OF IDIOPATHIC INFLAMMATORY MYOPATHIES

Treatment Of Psoriasis With Interferon Induced Helicase C Domain 1 (IFIH1) Inhibitors

Methods for treating pulmonary non-tuberculous mycobacterial infections

Cytotoxic actin-targeting compounds

NANOPARTICLE IMMUNOCONJUGATES

CHIMERIC CHLOROTOXIN RECEPTORS

Compositions and methods for treating lysosomal disorders

COMBINATION OF POLYETHYLENE GLYCOL AND RAPAMYCIN AND USE THEREOF

ANTI-TGF-BETA ANTIBODY FORMULATIONS AND THEIR USE

Combination of micheliolide derivatives or nanoparticles with ionizing radiation and checkpoint inhibitors for cancer therapy

Genetically modified probiotics for oral delivery of renin-angiotensin related therapeutic proteins and peptides

COMPOSITION OF LACTIC ACID BACTERIUM FOR USE IN PREVENTING OR TREATING RETT SYNDROME

Compositions and Methods for TTR Gene Editing and Treating ATTR Amyloidosis Comprising a Corticosteroid or Use Thereof

ANTIBODIES BINDING RANKL AND USES THEREOF

IMMUNOMODULATING TUMOR NECROSIS FACTOR RECEPTOR 25 (TNFR25) AGONISTS, ANTAGONISTS, AND IMMUNOTOXINS

Neo-Islets Comprising Stem and Islet Cells and Treatment of Diabetes Mellitus Therewith

Certain (2s)-n-[(1s)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitors

Heterodimeric Fc-fused proteins

COMPOUNDS AS CD73 INHIBITORS

COMPOUNDS AND METHODS FOR TREATING BACTERIAL INFECTIONS

Triazolopyrimidine compounds and uses thereof

METHODS AND COMPOSITIONS FOR IMPROVING COGNITIVE FUNCTION

METHODS PROVIDING A THERAPEUTIC MACROMOLECULE AND SYNTHETIC NANOCARRIERS COMPRISING IMMUNOSUPPRESSANT LOCALLY AND CONCOMITANTLY TO REDUCE BOTH TYPE 1 AND TYPE IV HYPERSENSITIVITY

METHODS AND COMPOSITIONS FOR TREATING AND DIAGNOSING A SAGE1-RELATED CONDITION

Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders

BIASED IL2 MUTEINS METHODS AND COMPOSITIONS

Methods and compositions for reducing tactile dysfunction and anxiety associated with autism spectrum disorder, Rett syndrome, and fragile X syndrome

THERAPEUTIC INTERACTIONS OF LEUCOMETHYLTHIONINIUM

FGFR/PD-1 COMBINATION THERAPY FOR THE TREATMENT OF CANCER

METHOD FOR TREATING CANCER BY ADMINISTRATION OF ANTIBODIES THAT BIND TO EXTRACELLULAR REGION PORTION OF MCEMP1 PROTEIN

CYCLOALKANE-1,3-DIAMINE DERIVATIVE

METHOD FOR IDENTIFYING AND TREATING STREPTOCOCCUS PYOGENES INFECTION

METHOD OF TREATING HYPERTENSION

Inhibitors of low molecular weight protein tyrosine phosphatase (LMPTP) and uses thereof

Prostate neoantigens and their uses

Fagopyrum Nutraceutical Compositions

CHEMICAL COMPOUNDS

MicroRNA (miRNA) and Downstream Targets for Diagnostic and Therapeutic Purposes

COMPOSITIONS COMPRISING PKC-BETA INHIBITORS AND PROCESSES FOR THE PREPARATION THEREOF

Certain (2S)-N-[(1 s)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitors

METHODS OF TREATING CANCER

Quinolin-2-one derivatives

TREATMENT OF NEUROLOGICAL DISORDERS WITH AVERMECTINS

Barrier system

MICROBIAL COMBINATIONS WITH MODULATORS OF THE OPIOID SYSTEM AND USES THEREOF

SUBSTITUTED HYDANTOINAMIDES AS ADAMTS7 ANTAGONISTS